Glucaric acid

Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Glucaric acid?

Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Glucaric acid

MeSH term MeSH ID Detail
Arthritis, Rheumatoid D001172 3 associated lipids
Liver Diseases D008107 31 associated lipids
Occupational Diseases D009784 42 associated lipids
Kidney Diseases D007674 29 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Leukemia P388 D007941 43 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Myocardial Infarction D009203 21 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Per page 10 20 50 100 | Total 85

PubChem Associated disorders and diseases

What pathways are associated with Glucaric acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Glucaric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Glucaric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Glucaric acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with Glucaric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Glucaric acid?

Knock-out

Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Glucaric acid

Download all related citations
Per page 10 20 50 100 | Total 1061
Authors Title Published Journal PubMed Link
pmid:15180183
pmid:15160289
Scheiber-Mojdehkar B et al. Non-transferrin-bound iron in the serum of hemodialysis patients who receive ferric saccharate: no correlation to peroxide generation. 2004 J. Am. Soc. Nephrol. pmid:15153577
Hanausek M et al. Modulation of biomarkers during chemoprevention of mouse lung tumorigenesis by D-glucarate. 2004 Chest pmid:15136473
Walaszek Z et al. Mechanisms of lung cancer chemoprevention by D-glucarate. 2004 Chest pmid:15136472
Koller WC et al. Metabolism of glucurolactone to glucarate in Parkinson's disease. 1992 Neurology pmid:1513472
Silverstein SB and Rodgers GM Parenteral iron therapy options. 2004 Am. J. Hematol. pmid:15114602
Okada DR et al. Early detection of infarct in reperfused canine myocardium using 99mTc-glucarate. 2004 J. Nucl. Med. pmid:15073263
pmid:15050885
Hanausek M et al. Detoxifying cancer causing agents to prevent cancer. 2003 Integr Cancer Ther pmid:15035900
Silverberg D et al. The use of androgens in anaemia resistant to erythropoietin and i.v. iron in patients with heart and renal failure. 2004 Nephrol. Dial. Transplant. pmid:15031380
Lakatos A et al. AlIII ion complexes of saccharic acid and mucic acid: a solution and solid-state study. 2004 Chemistry pmid:15007818
Charytan C et al. Safety of iron sucrose in hemodialysis patients intolerant to other parenteral iron products. 2004 Nephron Clin Pract pmid:14988600
Gupta KP and Singh J Modulation of carcinogen metabolism and DNA interaction by calcium glucarate in mouse skin. 2004 Toxicol. Sci. pmid:14976333
WHITE LP et al. The immediate hematologic effects of intravenous saccharated iron oxide. 1952 Blood pmid:14953947
LEVVY GA The inhibition of beta-glucuronidase by derivatives of saccharic acid. 1952 Biochem. J. pmid:14915974
HOLLY RG Intravenous iron: evaluation of the use of saccharated iron oxide in iron deficiency states in obstetrics and gynecology. 1951 Blood pmid:14869375
CAMERON DG et al. Some effects of intravenous injections of saccharated iron oxide on serum iron and unsaturated iron binding capacity. 1951 Can Med Assoc J pmid:14792459
CAMERON DG et al. Treatment of iron deficiency anaemia with saccharated iron oxide given by the intravenous route. 1951 Can Med Assoc J pmid:14792458
pmid:14767009
Manley HJ and Grabe DW Determination of iron sucrose (Venofer) or iron dextran (DexFerrum) removal by hemodialysis: an in-vitro study. 2004 BMC Nephrol pmid:14718064
Tutor-Crespo MJ et al. Assessment of copper status in epileptic patients treated with anticonvulsant drugs by measuring the specific oxidase activity of ceruloplasmin. 2003 Epilepsy Res. pmid:14642999
Breborowicz M et al. Effect of iron sucrose on human peritoneal mesothelial cells. 2003 Eur. J. Clin. Invest. pmid:14636286
Folkert VW Intravenous iron therapy in chronic kidney disease and peritoneal dialysis patients. 2003 Nephrol Nurs J pmid:14621635
Danielson BG and Beshara S Pharmacokinetics and utilization of iron sucrose. 2003 Am. J. Kidney Dis. pmid:14582057
Geisser P Reactivity of iron compounds. 2003 Am. J. Kidney Dis. pmid:14582056
Verma P et al. Decolorization of synthetic dyes using a copper complex with glucaric acid. 2004 Chemosphere pmid:14575741
Mukhin IV and Nikolenko VIu [Experimental systemic enzyme therapy of gouty and primary glomerulonephritis]. 2003 Jul-Aug Eksp Klin Farmakol pmid:14558349
Colfer M Achieving optimal patient outcomes with intravenous iron. 2003 Nephrol Nurs J pmid:14533524
Blaustein DA et al. The safety and efficacy of an accelerated iron sucrose dosing regimen in patients with chronic kidney disease. 2003 Kidney Int. Suppl. pmid:14531777
Séronie-Vivien S et al. Epoetin alfa and intravenous iron sucrose to treat severe anemia in a patient with chronic radiation enteropathy: a case report. 2003 Med. Oncol. pmid:14514981
Ohtani H et al. Comparison of technetium-99m-glucarate and thallium-201 for the identification of acute myocardial infarction in rats. 1992 J. Nucl. Med. pmid:1432160
pmid:14089452
Herzberg M et al. D-Glucaric acid and gamma-glutamyltransferase as indices of hepatic enzyme induction in pregnancy. 1977 Clin. Chem. pmid:13946
Abou-Issa H et al. Antitumour synergism between non-toxic dietary combinations of isotretinoin and glucarate. 1992 Eur. J. Cancer pmid:1388036
RICHTER GW Intranuclear aggregates of ferritin in liver cells of mice treated with saccharated iron oxide. Their possible relation to nuclear protein synthesis. 1961 J Biophys Biochem Cytol pmid:13741388
RICHTER GW The cellular transformation of injected colloidal iron complexes into ferritin and hemosiderin in experimental animals; a study with the aid of electron microscopy. 1959 J. Exp. Med. pmid:13620849
Pistelli A et al. [Contribution of glutathione to detoxification in alcoholism. Biochemical-clinical studies]. 1992 Clin Ter pmid:1358498
BOYLAND E et al. Enzyme activity in relation to cancer: inhibition of urinary beta-glucuronidase of patients with cancer of the bladder by oral administration of 1:4-saccharolactone and related compounds. 1957 Br. J. Cancer pmid:13510516
Pietrantonio AM et al. [Urinary measurement of D-glucaric acid in operating room personnel in the Modena USL 16 hospitals]. 1992 Jan-Nov G Ital Med Lav pmid:1345728
ELLIS JT Glomerular lesions and the nephrotic syndrome in rabbits given saccharated iron oxide intravenously; with special reference to the part played by intracapillary precipitates in the pathogenesis of the lesions. 1956 J. Exp. Med. pmid:13278460
DEVOE RW and MOSES LE Iron therapy in pregnancy; a comparative study of various modes. 1954 Calif Med pmid:13209356
NISSIM JA Toxic reactions after intravenous saccharated iron oxide in man; suggestions for improved preparations. 1954 Br Med J pmid:13115719
DESHMUKH PL Intravenous iron therapy with saccharated iron oxide. 1952 Ind Med Gaz pmid:12990194
pmid:12942420
Apostoli P et al. Relationship between PCBs in blood and D-glucaric acid in urine. 2003 Toxicol. Lett. pmid:12919720
Deicher R et al. High-dose parenteral iron sucrose depresses neutrophil intracellular killing capacity. 2003 Kidney Int. pmid:12846772
Silverberg DS et al. Effect of correction of anemia with erythropoietin and intravenous iron in resistant heart failure in octogenarians. 2003 Isr. Med. Assoc. J. pmid:12811950
pmid:12787877
pmid:12778887